BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 30171729)

  • 21. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
    Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
    Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
    Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
    DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma.
    Dasgupta P; Kulkarni P; Majid S; Hashimoto Y; Shiina M; Shahryari V; Bhat NS; Tabatabai L; Yamamura S; Saini S; Tanaka Y; Dahiya R
    Cell Death Dis; 2020 Aug; 11(8):660. PubMed ID: 32814766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA ZFPM2-AS1 regulates renal cell carcinoma progression via miR-130a-3p/ESCO2.
    Zhang G; Liu SL; Yi WT; Dong YP; Wan YX
    Kaohsiung J Med Sci; 2022 Jun; 38(6):530-541. PubMed ID: 35258173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
    Liu F; Chen N; Xiao R; Wang W; Pan Z
    Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
    Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
    Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma.
    Zhang S; Zhang D; Yi C; Wang Y; Wang H; Wang J
    Oncol Rep; 2016 Jan; 35(1):559-67. PubMed ID: 26499759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma.
    Jiao D; Wu M; Ji L; Liu F; Liu Y
    Oncol Res; 2018 Mar; 26(2):249-259. PubMed ID: 28550686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224-3p/HMGXB3 axis.
    Zhang G; Wang J; Tan W; Han X; Han B; Wang H; Xia Y; Sun Y; Li H
    Acta Histochem; 2021 Sep; 123(6):151752. PubMed ID: 34274607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.
    Mao W; Wang K; Xu B; Zhang H; Sun S; Hu Q; Zhang L; Liu C; Chen S; Wu J; Chen M; Li W; Peng B
    Mol Cancer; 2021 Nov; 20(1):142. PubMed ID: 34740354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
    Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
    Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A.
    Xiao W; Lou N; Ruan H; Bao L; Xiong Z; Yuan C; Tong J; Xu G; Zhou Y; Qu Y; Hu W; Gao Y; Ru Z; Liu L; Xiao H; Chen K; Yang H; Zhang X
    Cell Physiol Biochem; 2017; 43(6):2420-2433. PubMed ID: 29073615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL.
    Wang Y; Chen L; Wu Z; Wang M; Jin F; Wang N; Hu X; Liu Z; Zhang CY; Zen K; Chen J; Liang H; Zhang Y; Chen X
    BMC Cancer; 2016 Nov; 16(1):826. PubMed ID: 27842510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.
    Chen Q; Liu T; Bao Y; Zhao T; Wang J; Wang H; Wang A; Gan X; Wu Z; Wang L
    Cancer Lett; 2020 Jan; 469():68-77. PubMed ID: 31629934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2.
    Gao Y; Ma X; Yao Y; Li H; Fan Y; Zhang Y; Zhao C; Wang L; Ma M; Lei Z; Zhang X
    Oncotarget; 2016 Apr; 7(15):20324-37. PubMed ID: 26967247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway.
    Pan Y; Hu J; Ma J; Qi X; Zhou H; Miao X; Zheng W; Jia L
    Mol Carcinog; 2018 Aug; 57(8):1067-1077. PubMed ID: 29667779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.